D. Morelle

发表

Non‐clinical safety assessment of single and repeated intramuscular administration of a human papillomavirus‐16/18 vaccine in rabbits and rats

N. Garçon, L. Segal, D. Morelle, 2015, Journal of applied toxicology : JAT.

Non‐clinical safety and biodistribution of AS03‐adjuvanted inactivated pandemic influenza vaccines

F. Kuper, A. Didierlaurent, N. Garçon, 2015, Journal of applied toxicology : JAT.

Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP

R. Sinden, G. Cooke, M. Lievens, 2018, npj Vaccines.

A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive Adults

Linda A. Murray, N. Waters, E. Jongert, 2020, The Journal of infectious diseases.

Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study.

Paige E. Waterman, N. Waters, W. Robinson, 2016, The Journal of infectious diseases.

A phase IIA extension study evaluating the effect of booster vaccination with a fractional dose of RTS,S/AS01E in a controlled human malaria infection challenge.

M. Lievens, O. Ofori-Anyinam, M. Debois, 2021, Vaccine.

CXCR3+ T Follicular Helper Cells Induced by Co-Administration of RTS,S/AS01B and Viral-Vectored Vaccines Are Associated With Reduced Immunogenicity and Efficacy Against Malaria

A. Hill, T. Rampling, K. Ewer, 2018, Front. Immunol..

Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP

R. Sinden, G. Cooke, M. Lievens, 2016, Journal of Infectious Diseases.

Participation of two Ser-Ser-Phe-Tyr repeats in interleukin-6 (IL-6)-binding sites of the human IL-6 receptor.

P. Heinrich, S. Rose-John, A. Wollmer, 1996, European journal of biochemistry.

Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP

R. Sinden, G. Cooke, M. Lievens, 2018, npj Vaccines.

Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques

F. Tangy, N. Dumey, C. Lorin, 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques

F. Tangy, N. Dumey, C. Lorin, 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial

S. Adjei, M. Oneko, K. Otieno, 2022, The Lancet. Infectious diseases.

Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B with ChAd-MVA Vectored Vaccines Expressing ME-TRAP

R. Sinden, G. Cooke, M. Lievens, 2016 .

Local tolerance and systemic toxicity of single and repeated intramuscular administrations of two different formulations of the RTS,S malaria candidate vaccine in rabbits.

N. Garçon, L. Segal, M. Damsten, 2015, Regulatory toxicology and pharmacology : RTP.